Intravenous Immunoglobulin for Unverricht-Lundborg Disease.
NCT03351569
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
1
Enrollment
OTHER
Sponsor class
Conditions
Unverricht-Lundborg Disease
Interventions
DRUG:
Intravenous immunoglobulin
Sponsor
Azienda Socio Sanitaria Territoriale di Mantova